BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15193830)

  • 1. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome.
    Izumida N; Asano Y; Doi S; Wakimoto H; Fukamizu S; Kimura T; Ueyama T; Sakurada H; Kawano S; Sawanobori T; Hiraoka M
    Int J Cardiol; 2004 Jun; 95(2-3):261-8. PubMed ID: 15193830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between depolarization abnormality and repolarization abnormality in patients with Brugada syndrome: using body surface signal-averaged electrocardiography and body surface maps.
    Hisamatsu K; Kusano KF; Morita H; Takenaka S; Nagase S; Nakamura K; Emori T; Matsubara H; Mikouchi H; Nishizaki Y; Ohe T
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):870-6. PubMed ID: 15333077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms.
    Shimizu W; Matsuo K; Takagi M; Tanabe Y; Aiba T; Taguchi A; Suyama K; Kurita T; Aihara N; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Apr; 11(4):396-404. PubMed ID: 10809492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine model of Brugada syndrome using regional epicardial cooling of the right ventricular outflow tract.
    Nishida K; Fujiki A; Mizumaki K; Sakabe M; Sugao M; Tsuneda T; Inoue H
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):936-41. PubMed ID: 15333091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome.
    Watanabe A; Fukushima Kusano K; Morita H; Miura D; Sumida W; Hiramatsu S; Banba K; Nishii N; Nagase S; Nakamura K; Sakuragi S; Ohe T
    Eur Heart J; 2006 Jul; 27(13):1579-83. PubMed ID: 16760208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial distribution of repolarization and depolarization abnormalities evaluated by body surface potential mapping in patients with Brugada syndrome.
    Yokokawa M; Takaki H; Noda T; Satomi K; Suyama K; Kurita T; Kamakura S; Shimizu W
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1112-21. PubMed ID: 17038144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiographic predictors of Brugada type response during Na channel blockade challenge.
    Hermida JS; Denjoy I; Jarry G; Jandaud S; Bertrand C; Delonca J
    Europace; 2005 Sep; 7(5):447-53. PubMed ID: 16087108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetocardiography study on ventricular depolarization-current pattern in patients with brugada syndrome and complete right-bundle branch blocks.
    Kandori A; Miyashita T; Ogata K; Shimizu W; Yokokawa M; Kamakura S; Miyatake K; Tsukada K; Yamada S; Watanabe S; Yamaguchi I
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1359-67. PubMed ID: 17201843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome.
    Mizumaki K; Fujiki A; Tsuneda T; Sakabe M; Nishida K; Sugao M; Inoue H
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):667-73. PubMed ID: 15175062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perioperative management of patients with Brugada syndrome].
    Kubo K; Nishikawa K; Goto F
    Masui; 2005 Nov; 54(11):1247-52. PubMed ID: 16296362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous T wave alternans in a patient with Brugada syndrome--responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing.
    Nishizaki M; Fujii H; Sakurada H; Kimura A; Hiraoka M
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):217-20. PubMed ID: 15720462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome.
    Watanabe H; Chinushi M; Washizuka T; Sugiura H; Hirono T; Komura S; Hosaka Y; Yamaura M; Tanabe Y; Furushima H; Fujita S; Aizawa Y
    Pacing Clin Electrophysiol; 2005 May; 28(5):372-7. PubMed ID: 15869667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of body surface mapping to differentiate patients with Brugada syndrome from patients with asymptomatic Brugada syndrome.
    Hisamatsu K; Kusano KF; Morita H; Takenaka S; Nagase S; Nakamura K; Emori T; Matsubara H; Ohe T
    Acta Med Okayama; 2004 Feb; 58(1):29-35. PubMed ID: 15157009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chest pain and ST elevation associated with fever in patients with asymptomatic Brugada syndrome: fever and chest pain in Brugada syndrome.
    Aramaki K; Okumura H; Shimizu M
    Int J Cardiol; 2005 Sep; 103(3):338-9. PubMed ID: 16098400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome.
    Eckardt L; Bruns HJ; Paul M; Kirchhof P; Schulze-Bahr E; Wichter T; Breithardt G; Borggrefe M; Haverkamp W
    J Cardiovasc Electrophysiol; 2002 Aug; 13(8):742-9. PubMed ID: 12212690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brugada syndrome, manifested by propafenone induced ST segment elevation.
    Aksay E; Okan T; Yanturali S
    Emerg Med J; 2005 Oct; 22(10):748-50. PubMed ID: 16189048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrical space-time abnormalities of ventricular depolarization in patients with Brugada syndrome and patients with complete right-bundle branch blocks studied by magnetocardiography.
    Kandori A; Miyashita T; Ogata K; Shimizu W; Yokokawa M; Kamakura S; Miyatake K; Tsukada K; Yamada S; Watanabe S; Yamaguchi I
    Pacing Clin Electrophysiol; 2006 Jan; 29(1):15-20. PubMed ID: 16441712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome.
    Chinushi M; Iijima K; Tagawa M; Komura S; Furushima H; Aizawa Y
    J Electrocardiol; 2009; 42(4):367-73. PubMed ID: 19356768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.